Estradiol
- Product NDC
- 54348-702
- Requested package NDC
- 54348-702-90
- 11-digit product format
- 543480702
- Labeler code
- 54348
- Product ID
- 54348-702_ea93984c-32fa-71e9-e053-2995a90a84d2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ESTRADIOL
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PharmPak, Inc.
- Application
- ANDA040197
- Marketing category
- ANDA
- Marketing start
- 2019-07-09
- Substance
- ESTRADIOL
- Active strength
- 2 mg/1
- Pharmacologic classes
- Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040197-001 | ESTRADIOL | ESTRADIOL | 0.5MG | TABLET / ORAL | AB | 1997-10-22 | |
| A040197-002 | ESTRADIOL | ESTRADIOL | 1MG | TABLET / ORAL | AB | 1997-10-22 | |
| A040197-003 | ESTRADIOL | ESTRADIOL | 2MG | TABLET / ORAL | AB | RS | 1997-10-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A040197-001 | AB |
| A040197-002 | AB |
| A040197-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040197-001 | ESTRADIOL | 0.5MG | TABLET / ORAL | AB | 1997-10-22 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040197-002 | ESTRADIOL | 1MG | TABLET / ORAL | AB | 1997-10-22 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040197-003 | ESTRADIOL | 2MG | TABLET / ORAL | AB | RS | 1997-10-22 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040197-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040197-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040197-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Estradiol | ESTRADIOL | REMEDYREPACK INC. | 774ee81b-8e29-46af-ab12-7157f63b443b | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | Northwind Health Company, LLC | f6caf47a-1917-c493-e053-6394a90af63e | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | Northwind Health Company, LLC | f6cb38ab-fdff-9c07-e053-6294a90ad59a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | PD-Rx Pharmaceuticals, Inc. | f3a77482-f490-f350-e053-2a95a90ad8cb | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | NuCare Pharmaceuticals,Inc. | c8ac2e13-58d5-4e70-e053-2995a90aff04 | 2025-09-22 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | American Health Packaging | 265a1ee1-f314-4324-a2e1-0120a9a00a20 | 2025-05-02 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | A-S Medication Solutions | 3e84e3e7-4b50-407f-a215-45363b541384 | 2025-04-15 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | PD-Rx Pharmaceuticals, Inc. | d0d1c2c8-b175-4250-9343-d7db65b72e8f | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | NuCare Pharmaceuticals,Inc. | dd7d2d2a-e76b-7dfe-e053-2995a90a790a | 2025-02-26 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | PharmPak, Inc. | 20b50139-4e13-4f0c-aaf5-ecb83911d9e6 | 2025-01-16 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | Proficient Rx LP | 7e570b07-2a9e-49bf-b224-1e34f6eda3ab | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | A-S Medication Solutions | 7f3c96ce-c855-4372-95ba-7759dd82bcca | 2024-07-18 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | Bryant Ranch Prepack | 80d6644a-d6f2-48e7-a685-92c4255b19fe | 2024-04-05 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | Bryant Ranch Prepack | 414b846a-d6d9-4e8a-9632-12e296fc13c3 | 2024-04-04 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | Teva Pharmaceuticals USA, Inc. | c4936878-1643-4e7f-9b0d-e4957935aef2 | 2024-02-01 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 |
| Estradiol | ESTRADIOL | PharmPak, Inc. | 8f8c5a0b-4d7b-a5cb-e053-2995a90a494e | 2022-10-09 | Boxed warning, Warnings, Adverse reactions | 040197 ANDA040197 54348-702-90 54348-702 54348070290 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Estradiol
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ESTRADIOL | 2 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4TI98Z838E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 197659 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 8f8c5a0b-4d7b-a5cb-e053-2995a90a494e | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54348-702-90 | Estradiol | 90 in 1 BOTTLE | TABLET | 90 | 2 | |
| 54348-702-90 | Estradiol | 1 in 1 BOX | TABLET | 1 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197659 | estradiol 2 MG Oral Tablet | PSN | 8f8c5a0b-4d7b-a5cb-e053-2995a90a494e | 2 |
| 197659 | estradiol 2 MG Oral Tablet | SCD | 8f8c5a0b-4d7b-a5cb-e053-2995a90a494e | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 54348-702-90 | 54348070290 | 1 BOTTLE in 1 BOX (54348-702-90) / 90 TABLET in 1 BOTTLE | 1 bottle | 2019-07-09 | 0000-00-00 | No | No | Current |